We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Study Reveals Link Between Biomarkers and Heart Disease in Male HIV Patients

By MedImaging International staff writers
Posted on 10 Aug 2016
Print article
Image: Cardiac CT scans have revealed a link between higher inflammatory biomarkers and heart disease in male HIV Patients (Photo courtesy of the Multicenter AIDS Cohort Study).
Image: Cardiac CT scans have revealed a link between higher inflammatory biomarkers and heart disease in male HIV Patients (Photo courtesy of the Multicenter AIDS Cohort Study).
Results of a new Computed Tomography (CT) imaging study of male Human Immunodeficiency Virus (HIV) patients show a link between an increased prevalence of Coronary Artery Disease (CAD), and higher inflammatory biomarkers.

The results of the study were published in the June 27, 2016, issue of the Journal of the American Heart Association (JAHA). The study included 925 men, including 575 men with HIV. The researchers used CT angiography imaging to look for signs of sub-clinical CAD, and for the presence of seven inflammatory biomarkers. CAD includes narrowed arteries, and various changes in the characteristics of plaque deposits.

The study was carried out by researchers at the Keck School of Medicine, University of California (UC; Los Angeles, CA, USA), Johns Hopkins University (Baltimore, MD, USA) and five additional institutions. CT imaging enabled researchers to detect subclinical CAD, before clinical symptoms became apparent and provided more inflammatory markers than in previous studies. The researchers are also using cardiac Magnetic Resonance Imaging (MRI) to investigate coronary artery function, and changes in the heart muscle of HIV patients.

Research team leader Hossein Bahrami, MD, PhD, said, "We found that men infected with HIV had higher levels of inflammatory biomarkers than men who were not infected. There was a strong, independent association between the presence of these inflammatory biomarkers and subclinical CAD detected by CT scan. Although this study does not definitely prove the causal relationship between these markers and heart disease, it is suggestive of a possible role that persistent inflammation (even in HIV infected patients that are under appropriate treatments) may play in increasing the risk of heart disease in these patients. Inflammation has only recently been studied as a possible reason for chronic heart disease. Confirming the relationship between HIV-related inflammation and the marked increase of CAD among men infected with HIV allows us to move forward in our attempts to better manage the health of these patients according to their specific medical needs."

Related Links:
Keck School of Medicine, University of California
Johns Hopkins University
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Enterprise Imaging & Reporting Solution
Syngo Carbon
Portable X-Ray Unit
AJEX240H
Oncology Information System
RayCare

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.